FI833504L - 1-monofosfatestrar, 1,3-bisfosfatestrar och cykliska fosfatestrar av 9-(1,3-dihydroxi-2-propoximetyl)-guanin saosom antivirala aemnen - Google Patents

1-monofosfatestrar, 1,3-bisfosfatestrar och cykliska fosfatestrar av 9-(1,3-dihydroxi-2-propoximetyl)-guanin saosom antivirala aemnen Download PDF

Info

Publication number
FI833504L
FI833504L FI833504A FI833504A FI833504L FI 833504 L FI833504 L FI 833504L FI 833504 A FI833504 A FI 833504A FI 833504 A FI833504 A FI 833504A FI 833504 L FI833504 L FI 833504L
Authority
FI
Finland
Prior art keywords
propoximethyl
monophosphostestrar
fosphostestrar
bisphosphostestrar
dihydroxi
Prior art date
Application number
FI833504A
Other languages
English (en)
Finnish (fi)
Other versions
FI833504A7 (fi
FI833504A0 (fi
Inventor
Julien P H Verheyden
John C Martin
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of FI833504A0 publication Critical patent/FI833504A0/fi
Publication of FI833504A7 publication Critical patent/FI833504A7/fi
Publication of FI833504L publication Critical patent/FI833504L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/17Unsaturated ethers containing halogen
    • C07C43/174Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1745Unsaturated ethers containing halogen containing six-membered aromatic rings having more than one ether bound
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/178Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI833504A 1982-09-30 1983-09-29 1-monofosfatestrar, 1,3-bisfosfatestrar och cykliska fosfatestrar av 9-(1,3-dihydroxi-2-propoximetyl)-guanin saosom antivirala aemnen FI833504L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43193382A 1982-09-30 1982-09-30
US46427483A 1983-02-07 1983-02-07

Publications (3)

Publication Number Publication Date
FI833504A0 FI833504A0 (fi) 1983-09-29
FI833504A7 FI833504A7 (fi) 1984-03-31
FI833504L true FI833504L (fi) 1984-03-31

Family

ID=27029273

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833504A FI833504L (fi) 1982-09-30 1983-09-29 1-monofosfatestrar, 1,3-bisfosfatestrar och cykliska fosfatestrar av 9-(1,3-dihydroxi-2-propoximetyl)-guanin saosom antivirala aemnen

Country Status (7)

Country Link
EP (1) EP0105486A3 (de)
AU (1) AU565012B2 (de)
DK (1) DK448983A (de)
ES (4) ES526064A0 (de)
FI (1) FI833504L (de)
NO (1) NO833526L (de)
NZ (1) NZ205802A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
EP0138683A3 (de) * 1983-09-30 1988-01-20 Merck & Co. Inc. Purinderivate, ihre Verwendung in antiviralen Zubereitungen
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
CA1330794C (en) * 1987-03-27 1994-07-19 Phillip Frost Anti-viral compounds, dosage forms and methods
CN108794477A (zh) * 2018-08-06 2018-11-13 华东师范大学 一种n2取代鸟嘌呤类化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation

Also Published As

Publication number Publication date
ES542299A0 (es) 1986-04-01
ES542297A0 (es) 1986-04-01
ES8507550A1 (es) 1985-09-16
AU1972383A (en) 1984-04-05
ES8605533A1 (es) 1986-04-01
AU565012B2 (en) 1987-09-03
FI833504A7 (fi) 1984-03-31
ES8605520A1 (es) 1986-04-01
FI833504A0 (fi) 1983-09-29
ES8606870A1 (es) 1986-05-16
DK448983A (da) 1984-03-31
ES542298A0 (es) 1986-05-16
EP0105486A3 (de) 1984-05-16
EP0105486A2 (de) 1984-04-18
NZ205802A (en) 1986-10-08
ES526064A0 (es) 1985-09-16
DK448983D0 (da) 1983-09-29
NO833526L (no) 1984-04-02

Similar Documents

Publication Publication Date Title
NL930022I1 (nl) 9-(1,3 Dihydroxy-2-propoxymethyl)-guanine als antiviraal middel
FI831015A0 (fi) Cellulosaaemnen vilka gjorts transparenta och tillaempning av dem, foerfarande foer deras framstaellning och motsvarande behandlingsfoereningar
FI830719A0 (fi) Nya organopolysiloxaner, foerfarande foer deras framstaellning och anvaendning av dessa organopolysiloxaner
FI832857A7 (fi) Foerfarande och anordning foer sortering av laongstraeckta artiklar
FI833730L (fi) Antivirala kompositioner
FI834698A7 (fi) Karboxiamidoderivat av 5h-1,3,4- tiadiazolo/3,2-a/ pyridiner och foerfarande foer framstaellning av dessa.
FI831660A0 (fi) Teikomycin a2 rena individuella faktorer 1,2,3,4 och 5 och foerfarande foer deras framstaellning
FI832832A7 (fi) Substituerad 9-(1-0- eller 3-0-monosubstituerad eller 1,3-d1-0-substituerad propoxymetyl)-puriner som antiviral agenter
FI833504L (fi) 1-monofosfatestrar, 1,3-bisfosfatestrar och cykliska fosfatestrar av 9-(1,3-dihydroxi-2-propoximetyl)-guanin saosom antivirala aemnen
FI833337A0 (fi) Heterocykliska foereningar, deras framstaellning, dessa innehaollande kompositioner och foerfarandekontrollering av ooenskad tillvaext av vaexter
FI833215L (fi) Foerfarande och anordning foer sortering av en fibersuspension
FI834061A7 (fi) 2-piperazinylkinazolinderivat, framstaellning av dem och farmaceutiska kompositioner innehaollande dem
FI841584L (fi) Foerfarande foer framstaellning av mannitol och sorbitol.
FI833961L (fi) Foerfarande och mellanprodukter foer framstaellning av 1,1-dioxopenicillanoyl-oximetyl-6-beta-aminopenicillanat
FI833443L (fi) 1,2,3,4-tetrahydro-1-aminometyl-4-fenylisokinoliner och foerfaranden foer framstaellning av dem
FI834704A0 (fi) Nya karboxamidoguanidiner, foerfarande foer framstaellning av dem och laekemedelskompositioner innehaollande desamma
FI830559L (fi) Benzyleterderivat av pentitol, foerfarande foer framstaellning av dessa foereningar och dessa innehaollande produkter med foer vaexter vaextreglerande verkan
FI833025L (fi) Substituerade 1,3,4-benzotriazepiner, foerfarande foer deras framstaellning och deras anvaendning slaekemedel
FI833330L (fi) Saett foer inneslutning av hoeljeroer till foerbrukade braensleboxar foer braenslepatroner foer kaernkraftverk och valsverk foer genomfoerande av foerfarandet
FI821436L (fi) Foerfarande och anordning foer upphaengning av last
FI832994A7 (fi) Foerfarande och anordning foer matning av dokument till en kopieringsmaskin
FI821257A0 (fi) Foerfarande foer att snabbt montera och demontera en laett hallkonstruktion av tvao litet transportutrymme upptagande delar
FI823605A0 (fi) Foerfarande foer fysikalisk syrsaettning av livsmedel som ej innehaoller fett
FI834069L (fi) Hjaertmuskeln skyddande -butyrolaktonderivat med rytmstoerningar avlaegsnande verkan, foerfarande deras framstaellning och dessa innehaollane laekemedel
FI821786A0 (fi) Anordning foer kvistning, kapning och travning av traed

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SYNTEX (U.S.A.) INC.